Anh Le, | |
440 Dempsey Rd Unit 142, Milpitas, CA 95035-5631 | |
(415) 912-0286 | |
Not Available |
Full Name | Anh Le |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 440 Dempsey Rd Unit 142, Milpitas, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033616883 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 78206 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Anh Le, 440 Dempsey Rd Unit 142, Milpitas, CA 95035-5631 Ph: () - | Anh Le, 440 Dempsey Rd Unit 142, Milpitas, CA 95035-5631 Ph: (415) 912-0286 |
News Archive
Ongoing research around protective immunity against COVID-19 has not yet helped to define ways of how the public can protect themselves from the illness, minimize the symptoms, and avoid re-infection.
A flagship report by UNICEF has warned that the number of children worldwide suffering as a result of poor diets and a failing food system is alarmingly high.
Gentiva Health Services, Inc., a leading provider of home health and hospice services, today announced the closing of its acquisition of Odyssey HealthCare, Inc. in an all cash transaction for a price of $27 per share of Odyssey common stock, without interest, for an aggregate purchase price of approximately $1.0 billion, including fees and expenses.
There are two brain structures that a mouse just can't do without when it comes to hooking up with the mate of its dreams-and trying to stay off the lunch menu of the neighborhood cat. These are the amygdala, which is involved in the initial response to cues that signal love or war, and the hypothalamus, which coordinates the innate reproductive or defensive behaviors triggered by these cues.
Top-line data from the 270-patient global Phase 2/3 COVID-19 study expected Q1/2021. Top-line data from the 40-patient U.S. Phase 2 study of opaganib in severe COVID-19 expected in the coming days; this non-powered study was designed to evaluate safety and potential identification of preliminary efficacy signals in support of the global Phase 2/3 study of opaganib.
› Verified 8 days ago
Ms. Lisa Anani, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 45 N Milpitas Blvd, Milpitas, CA 95035 Phone: 408-946-6424 | |
Anne Chu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 770 E Calaveras Blvd, Milpitas, CA 95035 Phone: 408-945-2645 Fax: 408-945-2038 | |
Jyoshna Kolisetty, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1102 S Abel St Apt 337, Milpitas, CA 95035 Phone: 475-225-0566 | |
Dr. Suneet Kaur Dhillon, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 270 Enriquez Ct, Milpitas, CA 95035 Phone: 408-726-4465 | |
Jessica Park, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1833 N Milpitas Blvd, Milpitas, CA 95035 Phone: 408-726-4657 | |
Jade Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 611 S Milpitas Blvd, Milpitas, CA 95035 Phone: 408-945-2903 |